News Blocking Adenosine A2B Receptors Reduces Immunosuppression in Tumors A team of international researchers has demonstrated that blocking adenosine A2B receptors reactivates the immune system in the tumor microenvironment and demonstrates its effective
Technology Networks,
Researchers from the CiQUS of the USC have just published an article that opens up a new immunotherapeutic path against cancer.